Adverse outcome pathway development for assessment of lung carcinogenicity by nanoparticles

Tidsskriftartikel - 2021


Lung cancer, one of the most common and deadly forms of cancer, is in some cases associated with exposure to certain types of particles. With the rise of nanotechnology, there is concern that some engineered nanoparticles may be among such particles. In the absence of epidemiological evidence, assessment of nanoparticle carcinogenicity is currently performed on a time-consuming case-by-case basis, relying mainly on animal experiments. Non-animal alternatives exist, including a few validated cell-based methods accepted for regulatory risk assessment of nanoparticles. Furthermore, new approach methodologies (NAMs), focused on carcinogenic mechanisms and capable of handling the increasing numbers of nanoparticles, have been developed. However, such alternative methods are mainly applied as weight-of-evidence linked to generally required animal data, since challenges remain regarding interpretation of the results. These challenges may be more easily overcome by the novel Adverse Outcome Pathway (AOP) framework, which provides a basis for validation and uptake of alternative mechanism-focused methods in risk assessment. Here, we propose an AOP for lung cancer induced by nanosized foreign matter, anchored to a selection of 18 standardized methods and NAMs for in silico- and in vitro-based integrated assessment of lung carcinogenicity. The potential for further refinement of the AOP and its components is discussed in relation to available nanosafety knowledge and data. Overall, this perspective provides a basis for development of AOP-aligned alternative methods-based integrated testing strategies for assessment of nanoparticle-induced lung cancer.


Nymark P, Karlsson HL, Halappanavar S, Vogel U. Adverse outcome pathway development for assessment of lung carcinogenicity by nanoparticles. Frontiers in Toxicology 2021;3:21.
doi: 10.3389/ftox.2021.653386

Gå til Tidsskriftartikel

Relaterede projekter

Fornyet fokus på forskning i kemisk arbejdsmiljø Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment SmartNanoTox

NFA logo

Det Nationale Forskningscenter for Arbejdsmiljø | Lersø Parkallé 105 | 2100 København Ø. | T: 39 16 52 00 | F: 39 16 52 01 | M: | CVR: 15 41 37 00